We are live on ! Find out more
BBA

BLB&B Advisors Portfolio holdings

AUM $2.73B Turnover 8.25%
1-Year Est. Return 25.76%
This Fund
S&P 500
This Quarter Est. Return
+13.11%
1 Year Est. Return
+25.76%
3 Year Est. Return
+71.58%
5 Year Est. Return
+74.54%
10 Year Est. Return
+243.21%
AUM
$850M
AUM Growth
+$122M
Cap. Flow
+$31.1M
Cap. Flow %
3.65%
Top 10 Hldgs %
30.1%
Holding
286
New
14
Increased
81
Reduced
142
Closed
9
Avg Time Held
4.1 years
Top 10 Avg Time Held
2.6 years
Top 20 Avg Time Held
3.7 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 35.15%
2 Technology 12.88%
3 Healthcare 11.72%
4 Industrials 7.63%
5 Financials 7.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
GOOG icon
201
Alphabet (Google) Class C
GOOG
$4.22T
$370K 0.04%
6,300
-1,000
-14% -$56.1K
2016 Q4
9 quarters
AA icon
202
Alcoa
AA
$10.7B
$368K 0.04%
13,076
-2,810
-18% -$80.4K
2013 Q2
23 quarters
CAG icon
203
Conagra Brands
CAG
$6.77B
$364K 0.04%
13,112
-50
-0.4% -$1.15K
2013 Q2
23 quarters
SHW icon
204
Sherwin-Williams
SHW
$81.8B
$364K 0.04%
2,538
-270
-10% -$37.6K
2015 Q4
13 quarters
QQQ icon
205
Invesco QQQ Trust
QQQ
$487B
$353K 0.04%
1,967
-377
-16% -$64K
2014 Q4
17 quarters
XLU icon
206
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
$350K 0.04%
12,020
– –
2016 Q2
11 quarters
CFG icon
207
Citizens Financial Group
CFG
$26.7B
$349K 0.04%
10,745
-400
-4% -$13.9K
2016 Q2
11 quarters
WMT icon
208
Walmart Inc
WMT
$935B
$348K 0.04%
10,710
-978
-8% -$31.7K
2013 Q2
23 quarters
AEE icon
209
Ameren
AEE
$28.7B
$344K 0.04%
4,675
– –
2018 Q1
4 quarters
TMO icon
210
Thermo Fisher Scientific
TMO
$258B
$343K 0.04%
1,252
– –
2016 Q1
12 quarters
CEF icon
211
Sprott Physical Gold and Silver Trust
CEF
$7.12B
$336K 0.04%
27,073
– –
2013 Q2
23 quarters
DNP icon
212
DNP Select Income Fund
DNP
$3.72B
$333K 0.04%
28,882
+9,309
+48% +$104K
2017 Q3
6 quarters
NXPI icon
213
NXP Semiconductors
NXPI
$58.3B
$332K 0.04%
3,753
-650
-15% -$57.1K
2016 Q3
10 quarters
BCI icon
214
abrdn Bloomberg All Commodity Strategy K-1 Free ETF
BCI
$3.5B
$327K 0.04%
14,403
-2,994
-17% -$67.5K
2018 Q4
1 quarter
TFC icon
215
Truist Financial
TFC
$56.9B
$324K 0.04%
6,956
-1,999
-22% -$97.5K
2015 Q3
14 quarters
CSL icon
216
Carlisle Companies
CSL
$13.3B
$322K 0.04%
2,624
-120
-4% -$13.9K
2013 Q3
22 quarters
MAR icon
217
Marriott International
MAR
$101B
$314K 0.04%
2,513
– –
2016 Q4
9 quarters
VTI icon
218
Vanguard Morningstar Total Stock Market ETF
VTI
$697B
$314K 0.04%
2,173
-51
-2% -$7.12K
2015 Q4
13 quarters
IGSB icon
219
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$311K 0.04%
5,890
– –
2013 Q3
22 quarters
AMP icon
220
Ameriprise Financial
AMP
$44.4B
$310K 0.04%
2,422
+20
+0.8% +$2.48K
2016 Q3
10 quarters
NOC icon
221
Northrop Grumman
NOC
$71B
$310K 0.04%
1,151
-30
-3% -$8.18K
2017 Q3
6 quarters
PSX icon
222
Phillips 66
PSX
$115B
$310K 0.04%
3,255
– –
2013 Q2
23 quarters
SBUX icon
223
Starbucks
SBUX
$110B
$310K 0.04%
+4,170
New +$287K
2019 Q1
0 quarters
HPE icon
224
Hewlett Packard
HPE
$77.8B
$309K 0.04%
20,016
+68
+0.3% +$1.05K
2017 Q1
8 quarters
BEN icon
225
Franklin Templeton
BEN
$15.9B
$307K 0.04%
9,265
+475
+5% +$15K
2018 Q2
3 quarters

Similar funds

BLB&B Advisors's Q1 2019 Portfolio in Review

As of Q1 2019, BLB&B Advisors held 286 positions worth $850M, up 17% from $728M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

BLB&B Advisors deployed $31.1M of net new capital in Q1 2019, opening 14 new positions and adding to 81 existing holdings. Its largest new stake was Liberty Property Trust: 152,971 shares worth $7.41M.

By sector, the portfolio is most concentrated in Miscellaneous at 35% of assets, up from 34% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Ionis Pharmaceuticals, an estimated $4.05M trimmed.

  • BLB&B Advisors's largest Q1 2019 buy was Liberty Property Trust: 152,971 shares worth $7.41M.
  • BLB&B Advisors added most to Schwab US Mid-Cap ETF in Q1 2019, an estimated $5.28M increase.
  • BLB&B Advisors's biggest Q1 2019 reduction was Ionis Pharmaceuticals, cutting an estimated $4.05M.
  • BLB&B Advisors fully exited Biogen in Q1 2019, selling an estimated $360K.
  • BLB&B Advisors's ten largest holdings make up 30% of its $850M portfolio in Q1 2019.
  • BLB&B Advisors opened 14 new positions and closed 9 in Q1 2019.
  • BLB&B Advisors's portfolio value rose 17% quarter-over-quarter to $850M.

Based on BLB&B Advisors's 13F filing for Q1 2019, filed 19 Apr 2019.